Norganoid

3D-Brain-On-Chip for therapeutic testing

There is a high demand for replacing animal disease models in drug research with alternative solutions to significantly improve the certainty of preclinical studies. In particular, our aim is to establish a rigorous and patient specific drug screening platform for the earliest stages of drug development, facilitating a better understanding of brain impairment and mental disorders of individuals.